United States Onychomycosis Treatment Market Overview

Base Year: 2024

Historical Years: 2019–2024

Forecast Years: 2025–2033

Market Growth Rate: 5.11% (2025–2033)

The United States onychomycosis treatment market is expanding as awareness of fungal nail infections rises, along with increasing access to advanced topical and oral antifungal therapies. United States onychomycosis treatment market size reached USD 552 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 865.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.11% during 2025-2033.

United States Onychomycosis Treatment Industry Trends and Drivers:

Onychomycosis treatment demand in the United States market continues to rise because more people are contracting fungal nail infections while treatment options become more familiar to the public. The infection of nail bed known as onychomycosis creates pain and looks bad and produces discomfort in people who have it. The market demands for better treatment options has grown because population numbers rise among people vulnerable to fungal infections. The market continues to expand because people are increasingly focusing on both foot hygiene and health therefore they require medical solutions for nail infections. Healthcare providers now prescribe antifungal medications while using laser therapies and topical medicines to treat this condition thus expanding healthcare possibilities for patients.

The United States onychomycosis treatment market undergoes perpetual advancements in treatment solutions. Several pharmaceutical organizations maintain research programs for developing antifungal drugs with enhanced safety attributes alongside superior treatment effects. Laser therapy emerged as a non-invasive treatment option that gives patients fast and effective medical solutions for their needs. Telemedicine and digital health platforms make it possible for patients in remote areas to obtain medical diagnosis and treatment advice through innovative digital healthcare platforms. Market growth will increase because public recognition of onychomycosis and rising foot health importance. The onychomycosis treatment market faces ongoing obstacles because some therapies cost too much and patients struggle to follow required prescriptions. Sustainable growth of the United States onychomycosis treatment market depends on solving these market hurdles through education and cheaper treatment solutions.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-onychomycosis-treatment-market/requestsample

United States Onychomycosis Treatment Industry Segmentation:

The report has segmented the market into the following categories:

Disease Type Insights:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others

Treatment Type Insights:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment

Drug Class Insights: 

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

Distribution Channel Insights:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others

Regional Insights:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

  • Market Performance (2019–2024)
  • Market Outlook (2025–2033)
  • COVID-19 Impact on the Market
  • Porter's Five Forces Analysis
  • Strategic Recommendations
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145